Asia Pacific countries have written the plans to tackle antimicrobial resistance, but a new report shows many still struggle to fund them from their own budgets.
WHO estimates 5.2 million casualties by 2030, costing $148b. Fewer than half of Asia-Pacific countries fund their antimicrobial resistance (AMR) response mainly from domestic sources, according to a BMJ Journals report. The report noted that domestic funding was below 30% in 15 of 27 countries (56%). All four high-income countries and two Pacific Island countries reported 100% domestic funding, wh
Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.
Read full story on publisher site →